Conmed Stock Performance
| CNMD Stock | USD 67.69 0.83 1.24% |
CONMED has a performance score of 4 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.71, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CONMED's returns are expected to increase less than the market. However, during the bear market, the loss of holding CONMED is expected to be smaller as well. CONMED now shows a risk of 2.07%. Please confirm CONMED total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to decide if CONMED will be following its price patterns.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CONMED are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, CONMED may actually be approaching a critical reversion point that can send shares even higher in February 2025. ...more
Actual Historical Performance (%)
One Day Return 1.24 | Five Day Return (0.99) | Year To Date Return 0.5 | Ten Year Return 43.38 | All Time Return 19.9 K |
Forward Dividend Yield 0.012 | Payout Ratio | Last Split Factor 3:2 | Forward Dividend Rate 0.8 | Dividend Date 2025-01-03 |
1 | CONMED Updates FY24 Earnings Guidance | 10/30/2024 |
2 | CONMED Corporation Announces Financial Results and CEO Transition | 11/06/2024 |
3 | Disposition of 118 shares by Richard Glaze of CONMED at 70.69 subject to Rule 16b-3 | 11/20/2024 |
4 | Conmed Corp Trading Down 3.4 percent on Nov 26 | 11/26/2024 |
5 | Acquisition by Beyer Pat of 44677 shares of CONMED at 79.95 subject to Rule 16b-3 | 11/29/2024 |
6 | Heres Why Conmed is a Strong Growth Stock | 12/11/2024 |
7 | CONMED Corporation Declares Quarterly Cash Dividend | 12/13/2024 |
8 | CONMED Co. Shares Bought by Public Employees Retirement System of Ohio | 12/16/2024 |
9 | US Meniscus Treatment Market to Hit Valuation of US 479.38 Million By 2033 Astute Analytica | 12/23/2024 |
10 | Heres Why You Should Retain CONMED Stock in Your Portfolio for Now | 12/30/2024 |
11 | What Does CONMED Corporations Share Price Indicate | 01/02/2025 |
12 | Conmed Corp Announces Fourth Quarter 2024 Financial Results Release Date | 01/06/2025 |
13 | Pro-Dex Stock Skyrockets Over the Past Year A Must Buy | 01/07/2025 |
14 | Surgical Retractors Market Size to Reach USD 3.81 Billion by 2032 with a CAGR of 6.74 percent SNS Insider | 01/13/2025 |
15 | U.S. Cancer Biopsy Market and Competition Analysis, 2025-2030, Featuring Key Players - BD, IZI Medical Products, Johnson Johnson Services, Argon Medical Devices... | 01/16/2025 |
| Begin Period Cash Flow | 28.9 M |
CONMED |
CONMED Relative Risk vs. Return Landscape
If you would invest 6,366 in CONMED on October 20, 2024 and sell it today you would earn a total of 403.00 from holding CONMED or generate 6.33% return on investment over 90 days. CONMED is currently generating 0.1217% in daily expected returns and assumes 2.07% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of stocks are less volatile than CONMED, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CONMED Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CONMED's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CONMED, and traders can use it to determine the average amount a CONMED's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0588
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | CNMD | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.07 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average CONMED is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CONMED by adding it to a well-diversified portfolio.
CONMED Fundamentals Growth
CONMED Stock prices reflect investors' perceptions of the future prospects and financial health of CONMED, and CONMED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CONMED Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0398 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 2.97 B | ||||
| Shares Outstanding | 30.89 M | ||||
| Price To Earning | 188.03 X | ||||
| Price To Book | 2.21 X | ||||
| Price To Sales | 1.62 X | ||||
| Revenue | 1.24 B | ||||
| Gross Profit | 718.96 M | ||||
| EBITDA | 192.48 M | ||||
| Net Income | 64.46 M | ||||
| Cash And Equivalents | 33.35 M | ||||
| Cash Per Share | 1.09 X | ||||
| Total Debt | 991.25 M | ||||
| Debt To Equity | 1.45 % | ||||
| Current Ratio | 2.75 X | ||||
| Book Value Per Share | 30.21 X | ||||
| Cash Flow From Operations | 125.35 M | ||||
| Earnings Per Share | 4.22 X | ||||
| Market Capitalization | 2.09 B | ||||
| Total Asset | 2.3 B | ||||
| Retained Earnings | 452.53 M | ||||
| Working Capital | 304.92 M | ||||
| Current Asset | 393.34 M | ||||
| Current Liabilities | 119.72 M | ||||
About CONMED Performance
By analyzing CONMED's fundamental ratios, stakeholders can gain valuable insights into CONMED's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CONMED has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CONMED has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 183.94 | 136.98 | |
| Return On Tangible Assets | 0.09 | 0.07 | |
| Return On Capital Employed | 0.08 | 0.09 | |
| Return On Assets | 0.03 | 0.04 | |
| Return On Equity | 0.09 | 0.07 |
Things to note about CONMED performance evaluation
Checking the ongoing alerts about CONMED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CONMED help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CONMED has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: U.S. Cancer Biopsy Market and Competition Analysis, 2025-2030, Featuring Key Players - BD, IZI Medical Products, Johnson Johnson Services, Argon Medical Devices, Spectra Medical Devices More |
- Analyzing CONMED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CONMED's stock is overvalued or undervalued compared to its peers.
- Examining CONMED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CONMED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CONMED's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CONMED's stock. These opinions can provide insight into CONMED's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CONMED Stock analysis
When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |